Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
ImageneBio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ImageneBio, Inc.Listing unverified | Exercise | — | SEC | |
ImageneBio, Inc.Listing unverified | ExerciseD (derivative) | — | SEC | |
ImageneBio, Inc.Listing unverified | Buy | $8M | SEC | |
ImageneBio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ImageneBio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Kronos Bio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ImageneBio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ImageneBio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Replimune Group, Inc.Listing on record | Sell | $408.7K | SEC | |
Kronos Bio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $239.6K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $228.9K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $117K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $99.7K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $21.4K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $281.1K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $215.8K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $7.2K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $732.2K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $133K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $319.2K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $86.6K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $59.2K | SEC | |
Morphic Holding, Inc.Listing unverified | Sell | $606.5K | SEC |